Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,190.00
-3.00 (-0.06%)
Sep 4, 2026, 3:14 PM IST
Alkem Laboratories Market Cap
Alkem Laboratories has a market cap or net worth of 620.54 billion as of September 4, 2026. Its market cap has decreased by -1.93% in one year.
Market Cap
620.54B
Enterprise Value
605.69B
Revenue
150.81B
Ranking
n/a
PE Ratio
28.76
Stock Price
5,190.00
ChartMarket Cap Chart
Since December 23, 2015, Alkem Laboratories's market cap has increased from 165.20B to 620.54B, an increase of 275.62%. That is a compound annual growth rate of 13.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 620.54B | -5.75% |
| Dec 31, 2025 | 658.38B | -2.26% |
| Dec 31, 2024 | 673.62B | 8.29% |
| Dec 29, 2023 | 622.05B | 73.15% |
| Dec 30, 2022 | 359.26B | -17.09% |
| Dec 31, 2021 | 433.31B | 23.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zydus Lifesciences | 1.14T |
| Cipla | 1.13T |
| Laurus Labs | 1.01T |
| Mankind Pharma | 978.30B |
| Aurobindo Pharma | 951.16B |
| Glenmark Pharmaceuticals | 693.93B |
| Ipca Laboratories | 496.27B |
| Gland Pharma | 479.71B |